Kálmán K, Löcsey L, Hauck M, Leövey A
Int Urol Nephrol. 1980;12(4):367-74. doi: 10.1007/BF02082475.
The activity of the leucocyte inhibitory factor (LIF) stimulated with Concanavalin A was examined in chronic uraemic, haemodialysed patients. It was found that the LIF activity decreased in chronic uraemic patients as compared with the normal controls. The absolute T lymphocyte count and active E rosette formation also decreased. In in vitro experiments the authors have also examined the inhibitory effect of the so-called "middle-sized molecule" (MSM) on uraemic materials separated from the serum and the haemofiltrate. They observed that the materials with a molecular weight of 1000-1500 isolated both from the serum and the haemofiltrate significantly inhibited the Con A stimulated LIF production of normal lymphocytes and decreased the ratio of the active E rosette-forming T lymphocytes. On the basis of their experiments the MSM uraemic materials are considered responsible for the decreased immune reactivity of uraemic patients. These uraemic toxins can be dialysed.
对慢性尿毒症血液透析患者,检测了伴刀豆球蛋白A刺激下的白细胞抑制因子(LIF)活性。发现与正常对照组相比,慢性尿毒症患者的LIF活性降低。绝对T淋巴细胞计数及活性E玫瑰花结形成也降低。在体外实验中,作者还检测了所谓“中等大小分子”(MSM)对从血清和血液滤过液中分离出的尿毒症物质的抑制作用。他们观察到,从血清和血液滤过液中分离出的分子量为1000 - 1500的物质,显著抑制正常淋巴细胞的伴刀豆球蛋白A刺激的LIF产生,并降低活性E玫瑰花结形成T淋巴细胞的比例。基于他们的实验,认为MSM尿毒症物质是尿毒症患者免疫反应性降低的原因。这些尿毒症毒素可被透析清除。